[Hallucinogenic mushrooms].
Reingardiene D, Vilcinskaite J, Lazauskas R.
Medicina (Kaunas). 2005;41(12):1067-70.
Lysergic acid diethylamide.
O'Shea B, Fagan J.
Ir Med J. 2001 Jul-Aug;94(7):217.
Lysergic acid diethylamide intoxication.
Matthew H.
Br Med J. 1968 Feb 10;1(5588):380. doi: 10.1136/bmj.1.5588.380.
Is LSD toxic?
Nichols DE, Grob CS.
Forensic Sci Int. 2018 Mar;284:141-145. doi: 10.1016/j.forsciint.2018.01.006. Epub 2018 Feb 2.
Hallucinogens.
Brown RT, Braden NJ.
Pediatr Clin North Am. 1987 Apr;34(2):341-7. doi: 10.1016/s0031-3955(16)36219-8.
Adverse consequences of lysergic acid diethylamide.
Abraham HD, Aldridge AM.
Addiction. 1993 Oct;88(10):1327-34. doi: 10.1111/j.1360-0443.1993.tb02018.x.
[Hallucinogens].
Dubois-Poulsen A.
Annee Ther Clin Ophtalmol. 1973;24:149-63.
Lysergic acid diethylamide-associated intoxication in Hong Kong: a case series.
Li C, Tang MHY, Chong YK, Chan TYC, Mak TWL.
Hong Kong Med J. 2019 Aug;25(4):323-325. doi: 10.12809/hkmj197942.
Lysergic acid diethylamide (LSD-25) and schizophrenic reactions. A comparative study.
Langs RJ, Barr HL.
J Nerv Ment Dis. 1968 Aug;147(2):163-72. doi: 10.1097/00005053-196808000-00008.
Rave drugs: pharmacological considerations.
Klein M, Kramer F.
AANA J. 2004 Feb;72(1):61-7.
